Geron Announces Conference Call to Discuss Financial Results for the 2006 First Quarter
Thursday April 27, 7:30 am ET
MENLO PARK, Calif.--(BUSINESS WIRE)--April 27, 2006--Geron Corporation (Nasdaq:GERN - News) will announce its financial results for the 2006 first quarter on Friday, April 28, 2006, prior to the opening of the equity market. Thomas B. Okarma, Ph.D., M.D., Geron's chief executive officer, and David L. Greenwood, Geron's chief financial officer, will host a conference call for analysts and investors following the announcement at 8:00 a.m. Pacific Time, 11:00 a.m. Eastern Time.
Participants can access the conference call live via telephone by dialing 866-825-3209 (U.S.); 617-213-8061 (international). The passcode is 46494989. A live audio-only webcast is also available through a link that is posted on the Conferences page in the Investor Relations section of Geron's website at geron.com. The audio web broadcast of the conference call will be available for replay through May 22, 2006.
Geron is a biopharmaceutical company focused on developing and commercializing three groups of products: i) therapeutic products for oncology that target telomerase; ii) pharmaceuticals that activate telomerase in tissues impacted by senescence, injury or degenerative disease; and iii) cell-based therapies derived from its human embryonic stem cell platform for applications in multiple chronic diseases. |
